Suzhou Connect Biopharmaceuticals, Ltd. has announced the completion of a US$115 million series C round of financing. This round of financing was led by RA Capital Management. Lilly Asia Ventures, Boxer Capital and HBM Healthcare Investments also participated in the investment. Existing investment shareholder Qiming Venture Partners continued to join the latest investment. With the […] Connect Biopharmaceuticals Raises $115M Series C Round comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.